China Medical Technologies to Attend Credit Suisse Asian Healthcare Conference

BEIJING, Oct. 29 /Xinhua-PRNewswire-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced

in-vitro diagnostic products today announced that it will be attending the Credit Suisse Asian Healthcare Conference.

Date: November 5, 2008

Location: Beijing, China

China Medical Technologies' management team will discuss the Company's strategy, operations and growth opportunities, as well as its published results to date with securities analysts and institutional portfolio managers.

About China Medical Technologies, Inc.

China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products using Enhanced Chemiluminescence (ECLIA) technology and Fluorescent in situ Hybridization (FISH) technology, to detect and monitor various diseases and disorders, and system using High Intensity Focused Ultrasound (HIFU) for the treatment of solid cancers and benign tumors. For more information, please visit http://www.chinameditech.com .

For further information, please contact:

Winnie Yam

Tel: +86-10-6530-8833

Email: IR@chinameditech.com